Tetraphase Pharmaceuticals Stock Price - TTPH

-0.17 (-7.05%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Tetraphase Pharmaceuticals Inc TTPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.17 -7.05% 2.24 2.10 2.46 2.40 2.41 12:41:52
Bid Price Ask Price Spread Spread % News
2.24 2.25 0.01 0.44% 1 2
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,999 1,069,328 $ 2.25 $ 2,410,546 3,179,896 0.225 - 6.17
Last Trade Time Type Quantity Stock Price Currency
12:41:51 100 $ 2.24 USD

Tetraphase Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 16.27M 7.26M 6.89M $ 7.38M $ - -22.80 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 5.20%

more financials information »

Tetraphase Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TTPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.133.982.062.665,133,3320.115.16%
1 Month1.343.981.212.374,953,3670.9067.16%
3 Months1.643.980.562.291,689,3060.6036.59%
6 Months2.374.300.562.33909,692-0.13-5.49%
1 Year0.7946.170.2251.88647,9421.45182.12%
3 Years7.118.750.2253.27771,650-4.87-68.5%
5 Years42.795452.930.2256.00753,380-40.56-94.77%

Tetraphase Pharmaceuticals Description

Tetraphase Pharmaceuticals Inc is a biopharmaceutical company using its proprietary chemistry technology to create, develop and commercialize novel tetracyclines for serious and life-threatening conditions, including bacterial infections caused by multidrug-resistant, or MDR, bacteria.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.